Real-time data visualization of clinical trial progress is becoming more critical than ever before. With the current situation of COVID, both central and remote monitoring are paramount to trial success, and real-time data visualization has proven to help keep trials on track, yet keeping track of activity at all sites is a constant challenge. If site information that requires action doesn’t make it to the sponsor until hours, days or even weeks later, then it costs the trial precious time. Real-time visual data representations that enable targeting and the ability to proactively identify and monitor sites that are at risk gives the sponsor the power to implement corrective actions swiftly.
Learn how Phastar identified key elements for data visualization in clinical trials, and how to translate this data into actionable items.
Dr. Jennifer Bradford, Director of Data Science, PHASTAR
Dr. Jennifer Bradford leads PHASTAR’s data science group, a team of experienced data scientists that are applying advanced analytical approaches, including artificial intelligence and machine learning to maximize the value of clinical trial data. Dr. Bradford’s background in data science spans over 15 years and prior to joining PHASTAR in 2019, she worked for AstraZeneca and Cancer Research UK.
Paul Kassovic, Head of Technical Projects, Medrio
Paul Kassovic is Head of Technical Projects at Medrio, with a love for all things API’s, leads the charge on building and designing ways to ensure Medrio is interoperable with third-party systems and applications which has become increasingly critical in this virtual trial environment. Paul has over 5 years at Medrio, with a background of over 10 years of technical SaaS platform experience
Who Should Attend?
- Clinical Operations Professionals
- Clinical Data Management Professionals
- Clinical Technology Professionals
- Clinical Research Professionals
What You Will Learn
In this webinar, participants will:
- Hear about how Phastar identifies key elements for visualization in clinical trials
- Discover how to translate data into actionable items
- Learn how data visualization can prevent clinical trial delays
Medrio is the leading provider of eClinical technology for early-phase pharma, device, and diagnostics clinical trials. Founded in 2005, the company’s cloud-based EDC, eSource, eConsent, and ePRO solutions deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit www.medrio.com.